Medical TechnologistMemorial Sloan Kettering Cancer CenterNew York, New York, United States
Disclosure information not submitted.
Paper 41 - PDGFRβ AND C-ABL ACTIVATION ASSOCIATE WITH OUTCOME AND RESPONSE TO SORAFENIB IN DESMOID PATIENTS TREATED ON THE PHASE III ALLIANCE A091105 TRIAL
Friday, November 3, 202311:30 AM – 12:30 PM